Patent Valuation From a Practical View Point, and Some Interesting Patent Value Statistics From the Patentvaluepredictor Model

Patents have known finite terms. Conventional methods using income theory to value a patent analyze micro economic data to determine the anticipated economic benefit of owning the patent. This micro economic data includes market data indicating the gross sales and net income derived from the sale of products attributable to the patent, and any revenue derived from licensing the patent. Applying income theory to micro economic data to value a patent is labor intensive, costly, and complex. A micro economic analysis can be used to prove damages in patent infringement litigation. Do you allocate all value to the first patent? Patents 1, 2 and 3 each cover the first product. Patents 1, 2, and 4 cover a second product. Patents 2 and 5 cover the third product. V. The PatentValuePredictor Theory for Valuing PatentsNow let me tell you about the PatentValuePredictor model for valuing patents. How does the PatentValuePredictor model work? The model generates a nominal annual sales covered by the patent based solely upon measurable properties of the patent document and the value of the Gross Domestic Product (GDP). Finally, as the size of an evaluated patent portfolio grows, the PatentValuePredictor model's portfolio valuation becomes statistically more accurate. That explains why the PatentValuePredictor model determines an average value of enforceable patents is only about $2.8 million. The chart below shows the currently ten most valuable patents and their technology area.TEN CURRENTLY MOST VALUABLE PATENTS (AS OF 3/11/2004)Patent Issued Current Value ($) Assignee Technology 6,517,866 2/11/2003 1,797,722,689 Pfizer Inc. Pharma/Bio 6,500,987 12/31/2002 1,570,968,527 Teva Pharmaceutical Industries Ltd. Pharma/Bio 6,566,344 5/20/2003 1,481,848,538 Idenix Pharmaceuticals, Inc. Pharma/Bio 6,465,496 10/15/2002 1,408,931,126 Teva Pharmaceutical Industries, Ltd. Pharma/Bio 6,452,054 9/17/2002 1,220,308,695 Teva Pharmaceutical Industries, Ltd. Pharma/Bio 6,221,640 4/24/2001 1,194,927,644 Cubist Pharmaceuticals, Inc. Pharma/Bio 6,071,970 6/6/2000 1,107,999,343 NPS Pharmaceuticals, Inc. Pharma/Bio 6,319,919 11/20/2001 1,081,784,355 Davis; Bonnie (Syosset, NY) Pharma/Bio 5,610,034 3/11/1997 1,071,288,767 Alko Group Ltd. Pharma/Bio 6,022,716 2/8/2000 1,069,310,287 Genset SA Pharma/Bio While the Pharma/Bio tech area has held the lead for most valuable patents, the relative value of the most valuable patents has been increasing for decades. Note in the sequence of three charts below the trend of the relative value to increase over the decades.TEN MOST VALUABLE PATENTS ISSUED IN 1983Patent Issued Relative Value When Issued Assignee Technology 4,399,282 8/16/1983 1,343 Kabushiki Kaisha Yakult Honsha Pharma/Bio 4,375,514 3/1/1983 1,256 Schering, Aktiengesellschaft Pharma/Bio 4,372,948 2/8/1983 974 Kureha Kagaku Kogyo Kabushiki Kaisha Pharma/Bio 4,374,829 2/22/1983 661 Merck ; Co., Inc. Pharma/Bio 4,396,617 8/2/1983 660 Duphar International B.V. Pharma/Bio 4,399,276 8/16/1983 605 Kabushiki Kaisha Yakult Honsha Pharma/Bio 4,369,189 1/18/1983 551 Union Carbide Corporation Pharma/Bio 4,410,537 10/18/1983 507 Burroughts Wellcome Co. Pharma/Bio 4,399,148 8/16/1983 499 Union Carbide Corporation Pharma/Bio 4,372,953 2/8/1983 490 Otsuka Pharmaceutical Company, Limited Pharma/Bio TEN MOST VALUABLE PATENTS ISSUED IN 1993Patent Issued Relative Value When Issued Assignee Technology 5,252,474 10/12/1993 1,696 Merck ; Co., Inc. Pharma/Bio 5,256,558 10/26/1993 969 The Trustees of Rockefeller University Pharma/Bio 5,258,502 11/2/1993 868 Massachusetts Institute of Technology Pharma/Bio 5,268,273 12/7/1993 824 Phillips Petroleum Company Pharma/Bio 5,182,263 1/26/1993 823 Hoffmann-La Roche Inc. Pharma/Bio 5,187,241 2/16/1993 763 International Business Machines Corporation Pharma/Bio 5,262,568 11/16/1993 756 State of Oregon Pharma/Bio 5,198,563 3/30/1993 695 Phillips Petroleum Company Chem/Polymer 5,227,405 7/13/1993 690 Duke University Pharma/Bio 5,196,524 3/23/1993 679 Eli Lilly and Company Pharma/Bio MOST VALUABLE PATENTS ISSUED IN 2003Patent Issued Relative Value When Issued Assignee Technology 6,517,866 2/11/2003 3,374 Pfizer Inc. Pharma/Bio 6,566,344 5/20/2003 2,646 Idenix Pharmaceuticals, Inc. Pharma/Bio 6,602,861 8/5/2003 1,252 Research Corporation Technologies, Inc. Pharma/Bio 6,531,282 3/11/2003 1,225 Oligotrail, LLC Pharma/Bio 6,605,606 8/12/2003 1,109 Miravant Pharmaceuticals, Inc. Pharma/Bio 6,665,641 12/16/2003 884 ScanSoft, Inc. Software 6,602,503 8/5/2003 861 Biogen, Inc. Pharma/Bio 6,596,332 7/22/2003 841 Nestec S.A. Foods products 6,602,499 8/5/2003 824 The General Hospital Corporation Pharma/Bio RE038073 4/8/2003 804 Research Corporations Technologies, Inc. Pharma/Bio VI. ConclusionConventional valuation models are not generally applicable to patents.

What Patent Lawyer Calgary Can Do For Your IP Application?

The patent was principally directed at LCD displays for laptops. The claimant brought proceedings against three defendants in the patent county court.

The claimant then sought to have one of the patent claims amended in order to meet part of the defendant's case for revocation. The claimant argued that their action would fail if the courts did not allow the proposed amendments. In the original patent, there was no mention on how the module would be attached. In the original patent, no mention of this feature having inventive significance had been made.

If the first analysis was correct, then the amendment would be deemed to add new inventive significance to the patent and would offend the rule on adding matter.

Intellectual Property Law - Patent Infringement - Patent Law - Amendments Disallowed

The review of the invention is important, so it can be properly explain to the approving office and a patent lawyer Calgary with technical background and even experience aside from its law degree can verify the invention to the existing database of the IP if there is an existing or similar invention.By the way, Patent lawyer must verify efficiently whether the invention is definitely original, as submitting an invention that is not new can become a problem later. Keep in mind that claims is a legal description that comes with the patent application. The claim is one that draws the line between your invention and others, so making sure that you have describes in details how someone could possibly copy the invention is the key to taking an infringement case to anyone who would dare copy your invention.; Given this fact, hiring a Patent lawyer Calgary can give your claims the best legal protection possible.

Patent filling in India

Your lawyer should be responsible for all the imminent hurdles at the patent office. All what you need is a patent or a copyright. The rest should be left to your lawyer. As a businessman, you should evaluate the whole process and see if it makes sense employing a lawyer to take you through the process. Keep in mind that both you and your lawyer have a common goal and this is seeing that you succeed in getting your trademark or patent.

How to Register a Trademark - Employing the Services of a Trademark Or Patent Lawyer

A patent agent or lawyer can help you with those issues before applying for an invention patent.Patent are one of the most valuable competitive and technological information source available today and most important is that, its freely and easy accessible through various patent databases. Patent bibliographic information provides lots of insights pertaining to the competitor's activity, market strategies, R;D focus and business strategies.The reason why you should carefully document your idea is the following - your Provisional Patent Application may be the only source of proof that you are the original inventor and entitled to reaping the benefits of the patent. It is very possible that since the time you have submitted your Provisional Patent Application, someone else filled out paperwork for regular patent.

Apart from online patent sites, there are several patent offices that manually search for patents.

How To Get A US Patent

Is It An Invention?

A patent is there to protect an 'invention', not simply an idea. If the answer is yes then your idea is not an invention, its simply the logical application of current day knowledge to a new problem and therefore you can't patent it.

In many ways the US patent system is more akin to what many people assume about patents over here, if your the first person come up with an idea then you can patent it. Patents cost money. Carrying out the searches and filing your patent application through an attorney will cost a few thousand pounds. Once you've got your patent you then have ongoing costs each year to patent offices to keep the patent active.

Another misconception is that once you have a patent no-one else can copy your idea. If the infringer is a large company, or several companies infringe your patent you need to be able to fund the legal action. Is the idea your looking to patent commercial enough to justify all this.

You may be looking to patent your invention to then license it to another company to produce.

A few patent help tips

When researching an invention you'll often need to read through existing patent applications to make sure your idea is new. The rest will simply be lesser claims the patent can fall back to should the higher claims ever be overturned or rejected by the patent examiner.

Patent claims are not exclusive.

Filing a patent application doesn't mean that any searching will be done. It will then be examined in detail by a patent examiner but even if the patent is awarded it can be overturned at any time if prior art can be proved. However even then bear in mind that searches are not necessarily as skilled as you may expect and patent office searches will not necessarily search anything other than previous published patent applications and filings.

There is no point giving the patent attorney too much information.

Should I Patent My Idea?

A U.S. patent is necessary to protect your rights if you have invented a unique product or come up with a new idea. A patent grants property rights to an inventor, and is issued by the U.S. Patent and Trademark Office. Venture Backed Companies ; Startups Patent, Trademark, ; Corporate Law

If you're wondering how to patent an idea, it's the same process as for an actual invention. A utility patent is usually the patent of choice because in most cases it offers the best protection. According to patent law, only the original inventor can file an application and receive a patent, but you can make use of a lawyer to prepare the application. Patent law also prohibits a person from filing an application based on an item someone else has invented.If you want more patent information before you file, it's prudent to do a lot of research and read through reliable sources.

Acquiring a Plant Patent

What Is A Patent?

Once a patent expires, the invention loses its protection.

The most common type of patent applied for and granted is the utility patent.

Recourse If A Patent Is Violated

You should speak with a patent lawyer before applying for a patent. Patent infringement as it relates to plant patents is not uncommon, as those who are aware of the value of a plant patent are also aware of the value of seeking out alternative methods of discovering new plants.The U.S. Patent Office generally prefers that plant patent applicants utilize a patent lawyer when trying to determine whether or not they have created or discovered a new plant variety or species. Patent lawyers have attempted to get the word out that there is something known as a plant patent. Of course, this begs the question, why would anyone create a plant if they are unaware that they can retain a patent lawyer and apply to the U.S. Patent Office for a plant patent?

A patent lawyer can help protect a patent applicant's right to protect their financial interests. A patent lawyer with experience is a much better choice than a patent lawyer without experience, obviously. A patent lawyer can explain the maintenance fees associated with receiving a patent, how long it takes before you can expect your patent to be granted, and how to go about protecting your patent rights. Patent infringement issues can then be handled quickly, and often without a great expense as any indication of patent infringement can be immediately delved into by your patent lawyer.

India Patent Law

The due diligence process must take into consideration the competitive patent landscape.

Are the patents paid up in the Patent Office?

Do at least some of the patent claims cover the seller's products?

In that transaction, my client, a large manufacturer, sought to expand its non-commodity product offerings by acquiring "CleanCo", a small manufacturer of a patented consumer product. My client found CleanCo to be a good target for acquisition because CleanCo's product met a strong consumer need and, at that time, commanded a premium price in the market.

Due diligence revealed that CleanCo had few assets: the small manufacturing plant, limited but growing sales and distribution and several patents covering the sole CleanCo product. CleanCo owned the patents and had kept the fees paid. CleanCo's patent attorney had done a good job on the patents: the CleanCo product was covered well by the patents and there were no obvious legal errors made in obtaining the patents. So, I gave the transaction the thumbs up from the patent perspective. When everything else looked positive, my client became the proud owner of CleanCo and its product.

Given the fact that more than $150 million was spent on the CleanCo acquisition, these marketing professionals not surprisingly believed that the competitive products must be infringing the CleanCo patents.

As a result of this increasing competition for the CleanCo product, price erosion began to occur.

In hindsight, the competition for the CleanCo product could have been anticipated during the M ; A due diligence process. The patent law and the entire are governed by the superintendence of General Controller of designs patients, trademark patent and by geographical indications.

Anyone can be granted patent for any of their invention whether it is a product or some process.

Patent Valuation From a Practical View Point, and Some Fascinating Patent Value Statistics From the Patentvaluepredictor Model

A patent is there to protect an 'invention', not simply an idea. In many ways the US patent system is more akin to what many people assume about patents over here, if your the first person come up with an idea then you can patent it. Patents cost money. Once you've got your patent you then have ongoing costs each year to patent offices to keep the patent active. Is the idea your looking to patent commercial enough to justify all this.

A few patent help tips

Patent claims are not exclusive.

Filing a patent application doesn't mean that any searching will be done. It will then be examined in detail by a patent examiner but even if the patent is awarded it can be overturned at any time if prior art can be proved.

There is no point giving the patent attorney too much information.

Should I Patent My Idea?

Can we apply any of these theories to value patents?III. Patents have known finite terms. Conventional methods using income theory to value a patent analyze micro economic data to determine the anticipated economic benefit of owning the patent. This micro economic data includes market data indicating the gross sales and net income derived from the sale of products attributable to the patent, and any revenue derived from licensing the patent. Applying income theory to micro economic data to value a patent is labor intensive, costly, and complex. A micro economic analysis can be used to prove damages in patent infringement litigation. As a result, you cannot simply evaluate the value of a patent once you know the financials relating to certain products that the patent covers. No one produces anything covered by the second through tenth patent. Do you allocate all value to the first patent? Surely the other nine patents have actual value to the company! Patents 1, 2 and 3 each cover the first product. Patents 1, 2, and 4 cover a second product. Patents 2 and 5 cover the third product. The model generates a nominal annual sales covered by the patent based solely upon measurable properties of the patent document and the value of the Gross Domestic Product (GDP). You can those details of the model in my earlier article entitled "A Macro-Economic Model Providing Patent Based Company Financial Indicators and Automated Patent Valuations " posted in the publications sections of both and Suffice it to say here that there is a heuristic relationship between measurable properties of patent documents and patent value. Finally, as the size of an evaluated patent portfolio grows, the PatentValuePredictor model's portfolio valuation becomes statistically more accurate. See for example the corporate patent portfolio value charts in my earlier article "A Macro-Economic Model Providing Patent Valuation and Patent Based Company Financial Indicators" posted in the publications sections of both and Finally, there are some other interesting statistics I would like to share with you that relate to valuation of patents. The chart below shows the currently ten most valuable patents and their technology area.TEN CURRENTLY MOST VALUABLE PATENTS (AS OF 3/11/2004)Patent Issued Current Value ($) Assignee Technology 6,517,866 2/11/2003 1,797,722,689 Pfizer Inc. Pharma/Bio 6,500,987 12/31/2002 1,570,968,527 Teva Pharmaceutical Industries Ltd. Pharma/Bio 6,566,344 5/20/2003 1,481,848,538 Idenix Pharmaceuticals, Inc. Pharma/Bio 6,465,496 10/15/2002 1,408,931,126 Teva Pharmaceutical Industries, Ltd. Pharma/Bio 6,452,054 9/17/2002 1,220,308,695 Teva Pharmaceutical Industries, Ltd. Pharma/Bio 6,221,640 4/24/2001 1,194,927,644 Cubist Pharmaceuticals, Inc. Pharma/Bio 6,071,970 6/6/2000 1,107,999,343 NPS Pharmaceuticals, Inc. Pharma/Bio 6,319,919 11/20/2001 1,081,784,355 Davis; Bonnie (Syosset, NY) Pharma/Bio 5,610,034 3/11/1997 1,071,288,767 Alko Group Ltd. Pharma/Bio 6,022,716 2/8/2000 1,069,310,287 Genset SA Pharma/Bio While the Pharma/Bio tech area has held the lead for most valuable patents, the relative value of the most valuable patents has been increasing for decades. Note in the sequence of three charts below the trend of the relative value to increase over the decades.TEN MOST VALUABLE PATENTS ISSUED IN 1983Patent Issued Relative Value When Issued Assignee Technology 4,399,282 8/16/1983 1,343 Kabushiki Kaisha Yakult Honsha Pharma/Bio 4,375,514 3/1/1983 1,256 Schering, Aktiengesellschaft Pharma/Bio 4,372,948 2/8/1983 974 Kureha Kagaku Kogyo Kabushiki Kaisha Pharma/Bio 4,374,829 2/22/1983 661 Merck ; Co., Inc. Pharma/Bio 4,396,617 8/2/1983 660 Duphar International B.V. Pharma/Bio 4,399,276 8/16/1983 605 Kabushiki Kaisha Yakult Honsha Pharma/Bio 4,369,189 1/18/1983 551 Union Carbide Corporation Pharma/Bio 4,410,537 10/18/1983 507 Burroughts Wellcome Co. Pharma/Bio 4,399,148 8/16/1983 499 Union Carbide Corporation Pharma/Bio 4,372,953 2/8/1983 490 Otsuka Pharmaceutical Company, Limited Pharma/Bio TEN MOST VALUABLE PATENTS ISSUED IN 1993Patent Issued Relative Value When Issued Assignee Technology 5,252,474 10/12/1993 1,696 Merck ; Co., Inc. Pharma/Bio 5,256,558 10/26/1993 969 The Trustees of Rockefeller University Pharma/Bio 5,258,502 11/2/1993 868 Massachusetts Institute of Technology Pharma/Bio 5,268,273 12/7/1993 824 Phillips Petroleum Company Pharma/Bio 5,182,263 1/26/1993 823 Hoffmann-La Roche Inc. Pharma/Bio 5,187,241 2/16/1993 763 International Business Machines Corporation Pharma/Bio 5,262,568 11/16/1993 756 State of Oregon Pharma/Bio 5,198,563 3/30/1993 695 Phillips Petroleum Company Chem/Polymer 5,227,405 7/13/1993 690 Duke University Pharma/Bio 5,196,524 3/23/1993 679 Eli Lilly and Company Pharma/Bio MOST VALUABLE PATENTS ISSUED IN 2003Patent Issued Relative Value When Issued Assignee Technology 6,517,866 2/11/2003 3,374 Pfizer Inc. Pharma/Bio 6,566,344 5/20/2003 2,646 Idenix Pharmaceuticals, Inc. Pharma/Bio 6,602,861 8/5/2003 1,252 Research Corporation Technologies, Inc. Pharma/Bio 6,531,282 3/11/2003 1,225 Oligotrail, LLC Pharma/Bio 6,605,606 8/12/2003 1,109 Miravant Pharmaceuticals, Inc. Pharma/Bio 6,665,641 12/16/2003 884 ScanSoft, Inc. Software 6,602,503 8/5/2003 861 Biogen, Inc. Pharma/Bio 6,596,332 7/22/2003 841 Nestec S.A. Foods products 6,602,499 8/5/2003 824 The General Hospital Corporation Pharma/Bio RE038073 4/8/2003 804 Research Corporations Technologies, Inc. Pharma/Bio VI. ConclusionConventional valuation models are not generally applicable to patents.

A Brief Overview on the Israeli Patent Practice

The due diligence process must take into consideration the competitive patent landscape.

Are the patents paid up in the Patent Office?

Does the seller really own the patents?

Do at least some of the patent claims cover the seller's products?

My client found CleanCo to be a good target for acquisition because CleanCo's product met a strong consumer need and, at that time, commanded a premium price in the market.

Due diligence revealed that CleanCo had few assets: the small manufacturing plant, limited but growing sales and distribution and several patents covering the sole CleanCo product. CleanCo owned the patents and had kept the fees paid. CleanCo's patent attorney had done a good job on the patents: the CleanCo product was covered well by the patents and there were no obvious legal errors made in obtaining the patents. So, I gave the transaction the thumbs up from the patent perspective.

The former application for patent was filed no more than 12 months from the latter;

An application for priority has been filed within two months from the filing date (of the Israeli application for patent);

A certified copy of the former application (specification and drawings) was provided to the Israeli Patent Authority within 12 months from the filing date;

In the case wherein the prior application is not drafted in an Israeli formal language, the Israeli Patent Authority may ask the applicant to provide a translation of the specification into an Israeli formal language (English being among such).The Israeli Patent Examination: The Israeli Patent Authority performs an examination to determine whether the application complies with the Israeli law and regulations. 3 Easy Steps To Patent ; Make Money Request a Free Inventor Kit Today!
Prosecution: The Israeli Patent Authority starts the examination process about four or five years after the filing date in Israel, depending on the field of the invention. Maintenance fees: An Israeli patent may be in effect 20 years from its filing date.

Before the end of the 18th year from the filing date: $1050.Alternatively, a patentee may pay $2250 in advance, for the entire 20 year period of the patent’s lifespan.A delay in paying maintenance fees may result in abandoning the patent.Patent attorneys: According to Israeli Patent Law, patent attorneys (as well as licensed practicing advocates) possess exclusive rights for wage brokering regarding patent prosecution, design and trademark registration, preparation of all documents for intellectual property authorities in Israel and abroad, and representation of applicants before the intellectual property authorities.Conventions: Israel is a member of most major international treaties on intellectual property rights, including:

Trade Related Aspects of Intellectual Property (TRIPS)

Paris Convention for the Protection of Industrial Property, Stockholm revision (1967).

Rome Convention (1961): International Convention for the Protection of Performers, Producers of Phonograms and Broadcasting Organizations

Patent Cooperation Treaty, (PCT) (Washington 1970)

Strasbourg agreement Concerning the International Patent Classification (1971).

Budapest Treaty on the International Recognition of the Deposit of Microorganisms for the Purposes of Patent Procedure (1977).

Universal Copyright Convention (1952).

Convention Establishing the World Intellectual Property Organization (1967).

Understanding Patent Rights

The due diligence process must take into consideration the competitive patent landscape.

Are the patents paid up in the Patent Office?

Do at least some of the patent claims cover the seller's products?

In that transaction, my client, a large manufacturer, sought to expand its non-commodity product offerings by acquiring "CleanCo", a small manufacturer of a patented consumer product. My client found CleanCo to be a good target for acquisition because CleanCo's product met a strong consumer need and, at that time, commanded a premium price in the market.

Due diligence revealed that CleanCo had few assets: the small manufacturing plant, limited but growing sales and distribution and several patents covering the sole CleanCo product. CleanCo owned the patents and had kept the fees paid. CleanCo's patent attorney had done a good job on the patents: the CleanCo product was covered well by the patents and there were no obvious legal errors made in obtaining the patents. So, I gave the transaction the thumbs up from the patent perspective. When everything else looked positive, my client became the proud owner of CleanCo and its product.

Given the fact that more than $150 million was spent on the CleanCo acquisition, these marketing professionals not surprisingly believed that the competitive products must be infringing the CleanCo patents. However, I found that each of these competitive products was a legitimate design-around of the patented CleanCo product.

As a result of this increasing competition for the CleanCo product, price erosion began to occur.

In hindsight, the competition for the CleanCo product could have been anticipated during the M ; A due diligence process. As the "chair' has improvement over the 'stool', the patent office granted a patent to Bartholomew for his invention.

The basic patent only has both positive and negative right, where as all improvement patent enables their owner to exclude others from practicing their patented products.

Electronic Notebooks and the Specifications to Prove Date of Invention in Patent Interferences

Is It An Invention?

A patent is there to protect an 'invention', not simply an idea. When you apply for a patent what you are doing is specifying, through text and drawings, how your invention works. If the answer is yes then your idea is not an invention, its simply the logical application of current day knowledge to a new problem and therefore you can't patent it.

In many ways the US patent system is more akin to what many people assume about patents over here, if your the first person come up with an idea then you can patent it.

If you've got to here then hopefully you have an invention that may be patentable. Patents cost money. Carrying out the searches and filing your patent application through an attorney will cost a few thousand pounds. Once you've got your patent you then have ongoing costs each year to patent offices to keep the patent active.

Another misconception is that once you have a patent no-one else can copy your idea. If the infringer is a large company, or several companies infringe your patent you need to be able to fund the legal action. Is the idea your looking to patent commercial enough to justify all this.

You may be looking to patent your invention to then license it to another company to produce.

A few patent help tips

When researching an invention you'll often need to read through existing patent applications to make sure your idea is new. The rest will simply be lesser claims the patent can fall back to should the higher claims ever be overturned or rejected by the patent examiner.

Patent claims are not exclusive.

Interestingly one of the aims of patents is to promote invention and innovation.

Filing a patent application doesn't mean that any searching will be done. It will then be examined in detail by a patent examiner but even if the patent is awarded it can be overturned at any time if prior art can be proved. If you want your application to have a level of commercial value (if your doing it for IP purposes) you need to also do a search. However even then bear in mind that searches are not necessarily as skilled as you may expect and patent office searches will not necessarily search anything other than previous published patent applications and filings.

There is no point giving the patent attorney too much information.

* The advantages of the invention.

Should I Patent My Idea?

Electronic Notebooks and the Requirements to Prove Date of Invention in Patent InterferencesThis paper contains an excerpt of an email I sent to the PIUG (Patent Information User's Group) email distribution list on November 30, 2003.1. In all other major jurisdictions, it is the date of filing of a patent application that is the earliest date allowed to as a date of invention, except where there are issues of theft of invention.2. Here, "inventor" means the person or persons who are named on the patent. (I use the word "patent" here to mean either patent or patent application, for simplicity.)

An Introduction to Patent Monetization Resources For Corporations and Entrepreneurs

for enterprises and entrepreneurs who want to monetize their UN-or under-used IP rights for the first time, it can be difficult to know where početi.Tržište patent income is not yet mature and, like other emerging markets, has established methodology and some experts are lead owners through the process. Today, there are as many as 17 different business models used. More likely to spring up as the market continues to evolve, even while some of the current models will surely fall away. With such a range of options, it is not surprising that those who wish to sell their patent rights may be confused about what path to take. This article is intended to provide an overview of how the corporate and individual IP owners can most effectively exercise their rights in today's market. Models discussed in this article were chosen because they are currently the most common. Significantly, because of the large variability in the patents and the individual needs of IP owners, the best model for a particular person or organization may actually the one that is not discussed here. However, it is hoped that after reading this, the corporation or firm wishing to sell their rights for the first time will be better able to understand and execute on opportunities and challenges present in the market today, the patent income.

is considering selling the patent to the Corporation directly without an intermediary? Forget about most IP owners assume that it is possible to sell their rights directly to a company that could play or seek to play in a product or technology area covered by the patent. This is rarely the case, however. When I was employed as a senior attorney in the consumer products company, it was corporate policy to refuse all unsolicited offers to purchase or license patents that have come into the organization. Thus, the owner is not likely to see their rights sold his company. This absolute prohibition on unsolicited ideas is not a policy in all companies, but in truth, few companies are now actively looking to acquire products and technologies from external sources (although this is beginning to change the drive towards open innovation in many companies). So, even if the patent is the perfect fit for the company's offerings, most organizations will still prefer to go on buying opportunity, because the external acquisition is part of their model of technology development. Therefore, it is doubtful that most patent owners can hope to successfully sell their rights directly to the corporation because the latter is not in the business of buying patents generally, and especially not by individual owners.

aggregators: Customers Patents, if the patent owner can get their foot in the door the past few years, companies have emerged to keep the business model focused on the purchase of patents held by others. Famous gather today are intellectually Ventures, RPX and Allied Security Trust. Each of these companies has a different reason to seek to acquire a patent, but everybody can serve as a resource for owners wishing to sell their IP rights in certain technology areas. However, there are many more patent owners to sell their rights of existing opportunities to collect purchases. As a result, if the owner gets a "no" answer, so he knows that because his patent is worth nothing to collect, or is it because you did not know the right people to get their rights before the aggregator business? For most IP owners, especially those who participate in profits in the market for the first time, to collect patent probably will not serve as direct customer of their rights.

Brokers: Facilitors patent sales, for the price, such as brokers ThinkFire, IPotential and IP Transactions Group can help IP owners present their patent on the likely buyer, most likely of which are patent aggregators, non-practicing entities ("NPE is ") and, sometimes, of the corporation. Using their relationships and reputation, brokers effectively serve as "filters" for potential acquirers of the patent to simplify and improve the quality of patent buying opportunities. Simply put, patent buyers trust their patent brokers to "separate the wheat from the chaff" to make it easier to recognize and act on good opportunities patent kupnje.posrednik who believes the patent buyer can thus present the latter with the opportunity to purchase that the buyer would not give a second glance that if the same patent was offered to them outside the broker-customer relationship. There is a significant cost to rent a broker, however - usually about 25% of the total sales price. Patent brokers also require exclusivity. So, when the patent selects a broker to represent him in the sale, he must believe that the broker will find the best deal. I still believe that the knowledge and expertise available with a good broker can allow the patent to obtain a final purchase price for its rights to more than justify the broker fees. Specifically, the best brokers maintain a large network of potential buyers of patents, including aggregators, NPE, and, in some cases, corporations that have expressed interest in buying third party IP rights.

I believe such a broad networks serve a critical role in improving the efficiency of markets potentially raising earnings final purchase price. When a patent is offered through the quality of a broker, he will ensure that each party involved in the process and knows who is offered the chance. Such transparency can also lead to an increase in final sales price when a prospective buyer seeks to ensure that no other potential buyer is entitled to the same. For example, a corporation may increase its bid to prevent the NPE from obtaining the patent for the purpose of bringing a lawsuit against the corporation. This scenario implies that they are most interested in obtaining a patent will make their best offers on the table, a fact which should improve the final price platili.daljnje benefit of selling through a good broker is that they typically will conduct market analysis of the right to set reasonable based on entry level prices. Specifically, the broker will set the price based on what comparable patents were sold in the past. These figures are not usually public, and brokers with a few sales under his belt will probably set more accurately the initial selling price on the basis that it is interested in information that enables him to do so. Significantly, even an experienced broker may be wrong to assess the likelihood of price floor, but when the patent has a number of likely buyers, the market usually will act to restore the price of another acceptable to potential buyers.

Watch Finders who say that brokers are a significant problem with many people who held the patent as a broker is that some are not "brokers" at all. Instead, they are "looking" for an aggregate of patents or other customers, such as NPE (but probably not a corporation). Like a regular broker, and asked for maintenance of customer relationships is likely. When acceptance of a patent to sell a potential buyer, asked probably already know that you will be purchased by your contacts. In this scenario, the viewfinder is actually little to earn 25% of compensation other than to maintain a relationship with the end customer. Moreover, many of these brokers actually "double dip" because they get a fee from the buyer the opportunity to make them, unlike other potential kupca.Tražilo therefore can hold divided loyalties: should they try to maximize the price obtained for his client patent, when they could never see an opportunity from which the seller again, or would they keep the price reasonable so as not to ruin their relationship with their customers that they could bring several options to purchase each year? Clearly, this scenario is rife with questionable ethics, but the reality of current earnings in the market is that no licensing is required for someone to call themselves "patent broker", a rule is definitely a "buyer beware." As things stand at present unregulated brokers in the market, the best way to find quality patent broker to seek recommendations from someone who understands the market and / or who has successfully sold patents through a broker in the past.

Watch Finders who say that brokers are a significant problem with many people who held the patent as a broker is that some are not "brokers" at all. Instead, they are "looking" for an aggregate of patents or other customers, such as NPE (but probably not a corporation). Like a regular broker, and asked for maintenance of customer relationships is likely. When acceptance of a patent to sell a potential buyer, asked probably already know that you will be purchased by your contacts. In this scenario, the viewfinder is actually little to earn 25% of compensation other than to maintain a relationship with the end customer. Moreover, many of these brokers actually "double dip" because they get a fee from the buyer the opportunity to make them, unlike other potential kupca.Tražilo therefore can hold divided loyalties: should they try to maximize the price obtained for his client patent, when they could never see an opportunity from which the seller again, or would they keep the price reasonable so as not to ruin their relationship with their customers that they could bring several options to purchase each year? Clearly, this scenario is rife with questionable ethics, but the reality of current earnings in the market is that no licensing is required for someone to call themselves "patent broker", a rule is definitely a "buyer beware." As things stand at present unregulated brokers in the market, the best way to find quality patent broker to seek recommendations from someone who understands the market and / or who has successfully sold patents through a broker in the past.

It is clear as mud now, right? As stated at the beginning of this article, earnings on the IP market is only now emerging as a viable way to get the value from the UN or under-utilized assets. Because of this, most owners of a patent is only beginning to be confused about how to proceed in a manner that maximizes the price obtained. If someone owns the rights to patents and trying to sell them today, it is my recommendation that you learn more about the process. And, as with many business situations, checking references and asking for recommendations from those with experience as a patent consultant and reseller of IP owners will be critical to success in earnings. Personally, I am looking forward to the day when there is more openness in the market, so that patent owners can better gauge the quality and qualifications of those participants

The "Humouse" Human-Animal Chimera Patent Challenge

What is a human being? In the past, it is a question in the appropriate manner contemplated by theologians, philosophers and anthropologists. But in the modern world of biotechnology, it has also become an issue to consider venture capitalists, patent lawyers and legislators.
Most members of the latter group May want to avoid this unpleasant, or at least impractical, the case as long as possible.

But, in cooperation with the social critic Jeremy Rifkin, president of the Foundation on Economic trends in the Washington, DC, decided to force the issue of applying for a patent in late 1997 on embryos and animals containing human cells - so-called "chimeras ".
"Chimera" as being composed of two cells of genetically different individuals, usually in combination at an embryonic stage. Rare are the natural human chimeras who were born when the embryonic cells fraternal twins in the uterus combine to create an individual. Scientists have also deliberately create cross-species chimeras like "GEEP", in which embryonic cells from goats and sheep are combined. The contemporary view suggests the Greek meaning "goat" Chimera is a fire-breathing creature that goat's body, lion's head and tail of a serpent. Some sources are represented by Chimera with three heads (lion's head as a principal, and then goat's head sprouted from his back, a snake or a dragon head to tail), but a popular myth once, fire, vomiting head. Very likely aspect of Chimera gradually became the name of synonymous with the vain dream.

Leading anti-biotech activist, has long opposed corporations "owning" patents on living organisms (or cells and genes). But corporations do not actually "own" genes or animals? What are patents? Patents are temporary monopolies (20 years) approved by the Government of the inventor as a way to encourage them to disclose how their inventions work publicly, so that other people will be able to use them.

is often reviled by the scientists, the patent system is actually information about the secret process of doing something like a peer-reviewed scientific publications - which was first revealed in getting a loan. Like patents, peer-reviewed research must disclose enough information so that other researchers can reproduce eksperiment.Privremenog monopolies have created valuable patents, which encourages people to invest in research and development projects of biotech companies.

Q chimeras - Activists are trying to patent fear

Scientists say that a decision on protest patent will have no impact on future chimeric-animal patents. Looking to treat a number of neuro-degenerative diseases, stem cells, Palo Alto, Calif.-based company, has a transplanted human neural stem cells in the brain of one thousand miševa.Miševi are technically chimeras, a mixture of two or more species.

Such animals, particularly mice, have been used in searching for ways to treat human diseases, including Parkinson's and Alzheimer's bolest.Sposobnost assessment of human cells in mice or other animals is critical to translate scientific discoveries into therapeutic medicine, so the bridge to the clinic . However, the use of such chimeric animals is the focus of a complicated patent case that is raising legal and ethical issues. In this case, opponents of patenting of living beings, applied for a patent himera.US Patent and Trademark Office (USPTO) refused to issue a patent for a human-animal chimeras in the application on the grounds that it would be almost too human.

The volatile debate bioengineered life forms, many disagree about the consequences of the biotechnology industry's recent slučaju.Kritičari who registered patent case say serious business and research implications. However, some leading researchers and industry observers say it is just another attempt to grab attention in a field packed with more heat than rational discussion. Stuart Newman, professor of cell biology and anatomy at the Medical School in New York, Valhalla, says he opposes the patenting of living beings. Newman, working with the Washington, DC, activist Jeremy Rifkin, filed a patent application in 1997 for a theoretical creature never actually made. For "tactical reasons," says Newman was eventually divided his patent application into two: one involves primates and other directed at other animals

.

using what he calls the "embryo Chimera technique," Newman attempted to patent the creature by combining human embryo cells with cells from an embryo from a monkey, ape or other animal to create a blend of both. Other scientists have used similar methods to create "GEEP" (part goat, part sheep) could be used for drug testing as a source of organs for transplantation in humans. After seven years and several rejections and appeals, the USPTO rejected both Newman's patent application in August 2004, saying, among other things, that this creature would be too close to humans. Newman and Rifkin let six months of the appeal period fire declared victory in February 2005. Both Rifkin and Newman said they expect a decision to prevent scientists and Biotechs from obtaining similar patents for 20 years, the time the patent is usually feasible. Rifkin says crossing species boundaries is a form of animal abuse and violation of nature and human dignity.
"The ruling has significant implications for the future of the biotech industry," says Rifkin, president of the nonprofit Foundation on Economic Trends, one of the most vocal critics of biotechnology products such as genetically modified organisms.

implications for the commercial interests are far-reaching. That means anyone applying for a patent for a human-animal chimeras should be denied. He expects the decision will be influenced stem cell, too. There are people who produce or express their intention to produce a mixture of humans and mice for research in order to test the potential of human stem cells. This decision does not block their ability to do that in their labs, but if they wanted to patent and market, and mixed human and animal organisms, it will be harder for them to commercialize it. However, a leading stem cell scientists say the case is likely to stop working on chimeric animals.

Twenty-five years, Diamond V. Chakrabarty, a U.S. scientist Ananda Chakrabarty, who worked for General Electric at that time, obtained the first patent on a living organism, genetically modified bacteria that consumes spills nafte.Patentni office initially denied program, believing that he could not patent living organisms, according to Brigid Quinn, USPTO spokesperson. The case landed in the United States Supreme Court, which held that "anything under the sun that a man" could be patented as long as "a new, non-obvious and useful ."

Since then, more than 436 transgenic or bioengineered animals have been patented, including 362 mice, 26 rats, 19 rabbits, 17 sheep, 24 pigs, two chickens, 20 cows, three dogs, and much more. Many say that 1980 has led to the birth of biotechnology in the United States. However, U.S. law clearly prohibits the patenting of people. One of the reasons we are denied the case of the examiner believes one or more claims covered by the Human bića.Pitanje that can be raised whether the case will affect future patents for the chimeric animals', the answer may be that the examiners always decide first if it is patentable subject, and people no. All found in nature are not patentable subject matter. It must be new, useful, non-obvious, and fully disclosed in writing. Each patent application reviewed its own merits.

Therefore, one can not say whether the case will affect future chimera patent application or not.
Irving L. Weissman, professor of cancer biology, pathology and developmental biology at Stanford University has created mice with brains that contain about 1% of human tissue. Weissman says the latest news reports that it plans to create a mouse with 100% of the human brain are "inaccurate." Pioneer in the field of stem cell research, Weissman is credited as the first scientist to identify and isolate hematopoietic stem cells from mice and humans. He says that the news reports prompted academic inquiry is made ​​to find out, in theory, as he is a university ethics panel thought of the idea. He says he has no current plans to create such a mouse.

Newman / Rifkin patent is "a new attempt to block the science," while "the use of human mouse chimeras is old," says Weissman. In 1988, J. Michael McCune patented the SCID-hu mouse, "severe combined immunodeficient mouse with human organs, bones, lymphatic tissue, thymus, and liver," says Weissman, who is also director of the Stanford Institute of Cancer / Stem cell biology and medicine and co-founder of Stem-cells and other companies. "A precedent exists, the findings were published a long time and people's lives are affected by these discoveries. Would you go back all those discoveries and be happy if the therapy was discovered by them are taken away?" Weissman dismisses the Newman / Rifkin case as a "typical Rifkin," adding that "one example does not have. This does not invalidate the others, so it's a hollow victory. The case is not precedent think ."

chimeric animals, and patents, are key to the ability of biotechnology to develop cures for human diseases. To protect their investment, for example, StemCells has more than 43 U.S. patents in the technology of stem cells, but no one is on bioengineered mice. If the private sector can not get a patent on their work and invention, it is unlikely to be involved in the work, because it takes so much time and effort and novca.Sposobnost to keep their return on investment is crucial. We concluded that mice backbone Biotechs, pharmaceuticals and drug development.

, however, adding a complex of genes on other things, for example mice, to increase the number of ethical problems. Why? Since mice simply could not develop a humanoid brain with self-consciousness. I like mice may be useful in finding treatments for human diseases of the brain important thing is that certain types of brain, not the genes have had. Human genes are not holy men.

yuckiest thing of all would be if public policy and are afraid of the Frankenstein fantasies peddled the clever activists into slowing biomedical advances that could improve the suffering of millions.

Rethinking scientific and legal precedent

since 1980, the Supreme Court that is legal in the United States to obtain patents on living organisms or their offspring.

In addition, the Government has drawn a line that would prevent pre-term human embryo, if it is appropriate to change from being patented. Neither is it stated how many human genes or cells of animals should contain before it could not be patented under the constitutional protection for members of the human community.

of human embryos can be patented? Working scientists worried that the fruits of science should not be used to harm society, Rifkin is a call several years ago to invent something novel, eagerly accepted, but also disturbing to warn the public about the inevitable consequences of unbridled commercialization living svijeta.Rezultat was human-animal chimeras , which could contain anything from tiny compared to most human cells.

This creature can not be made ​​(and thus is not), but I just had to show its effectiveness. Since it is known that the invention was patentable under existing standards and laws, it is accepted that the patent will be issued and then the possibility of exercising the right to prevent its implementation in the legal 20 years.

It is envisaged that public outrage at the possibility that such part-human, part-animal organisms can be produced and patented can reasonably lead to a re-evaluation of the legalities that are made bona fide commercial ventures of this kind possible.

of the new development specifically dealing with precedent Chakrabarty case, in which the Patent and Trademark Office (PTO) as opposed to granting the patent Dr. Ananda Chakrabarty and his employer, General Electric Corp., zaulje-eating bacteria.
The courts overturned that decision, absurdly, that bacteria are "more akin to inanimate chemical compositions ... [than] to horses and honeybees and raspberries and roses", a startling that Chakrabarty's microbe was a "man-made invention." Notwithstanding these differences, Chakrabarty decision served as a precedent for the issuance of patents on mice, pigs and cows, some containing introduced human genes, as well as the native human bone marrow.

Future Challenges

the legislature has not specifically addressed the question of whether humain beings can be patented or not. Similarly, the Chakrabarty Court did not address whether human beings are patentable subject matter. "PTO (Patenr and Trademark Office), commented that" when the patent issues are the greatest first impression, in the absence of clear legislative intent and guidance from the courts, it is incumbent on the Office to continue with caution. "
New circumstances are given the opportunity to finally open the question of whether or not the current PTO policy holders of life of patents on genes, cells, etc. is legal. With the PTO now say that the ranting of certain patents on human cells may in fact be questioned, the question of the legitimacy of the patent life becomes a matter of great interest to public policy within the government itself.

the question is whether the human gene pool, and life itself can be patented is one of the major problems of the coming century. If the current PTO policy must stand, several life science companies in the world will gain control over the genetic blueprints of millions of years of biological evolution, giving them tremendous power over the market of biological 21st the century. These legal challenges are designed to block and reverse the potential monopoly of the biology of the planet.

To Patent Or to Copyright? Learn How to Legally Protect Your Work

There is usually confusion on no matter whether 1 has a copyright in a function, or regardless of whether they should get a patent for protection.

In this write-up, you will finally come away with a clear understanding on the distinction in between these two sorts of intellectual property.

The Rights Afforded by Copyright Protection:

Copyright protects the expression of literary and artistic function. When a person creates an original function, and have put it in a fixed form, they automatically own the copyright to that function. What this means is the individual owns the rights to: reproduce the function, carry out the work, record the work, broadcast the function, translate the function, and adapt the function into a diverse form (i.e. a novel into a screenplay).

Copyright Protects Expressions, Not Concepts:

A widespread misunderstanding is that copyright protects ideas. Copyright protects the expression of an thought, but not the concept itself. What this indicates is one hundred many people can write an article about copyright. Even so, we every single own the copyright to our specific articles considering that every 1 is an original and fixed piece of work.

The Ideas of Originality and Fixation in Copyright:

"Originality" and "fixed" are two crucial terms in copyright. Although the function does not have to be the very first of its type (i.e. this is not the 1st article ever written about copyright), the expression has to be original (I'm not plagiarizing this post - I have written it myself with original sentence structures and an original flow to the post). As for becoming 'fixed' there is a very fantastic cause for this requirement. For a function to fall under copyright law, it have to be in a fixed form - considering it would be extremely hard to prove what was designed if there was no copy of it! A "fixed" form could be one thing written on paper, recorded onto a CD, recorded on video, or saved on a flash drive.

What Copyright Protects:

Copyright covers a wide wide variety of artistic works and they are commonly characterized as follows:

o Literary Work (novels, poems, computer system software source code)
o Artistic/Visual Arts (sculpture, drawing, illustration, graphic design, plans, maps, photographs, architectural function)
o Dramatic Work (films, videos, choreography), Musical (musical composition with or with no words)
o Sound Recordings (recordings of music, drama, or lectures)
o Serial & Periodicals (periodicals, newspapers, magazines, bulletins, newsletters, annuals, journals, proceedings of societies)

Patents Safeguard Inventions:

Patents protect new inventions or valuable improvements to existing inventions. Examples are inventions or discoveries of any new and helpful method, apparatus, machine, or composition of matter, or any new and beneficial improvement thereof.

Patents Have to Be Obtained:

Unlike copyright which is automatic, a patent need to be granted by the government to be valid and can take up to 3 years with considerable economic investment. If you are going to file for a patent, it is especially crucial you do not disclose your invention to anyone, mainly because it could be grounds to refuse your patent application.

Due to the fact there is an application approach for patents, a patent granted in one country is not valid in an additional. As such, you will will need to apply separately in every single country, or by way of the Patent Cooperation Treaty (PCT).

Qualifications For Patents:

For an item/method to qualify for a patent, it must frequently be:

o new
o beneficial
o inventive (in other words, it need to not be an apparent invention to a person in the field)

Durations of Patents:

As soon as you effectively hold a patent, you have a limited time (ordinarily around 20 years) exactly where you are the only one who can make this item or use the patented procedure before it is made public.

Disclaimer

The above info is meant as a general guide to further your copyright and patent understanding and does not constitute legal advice. For concerns about your precise function, you really should consult an intellectual property lawyer in your country.

Technology Insight Report: Light Emitting Diode Or Led Technology In Lighting

Light Emitting Diode or LED in lighting can be traced back to 1927 despite the fact that it did not make an entrance into commercial till considerably later. Having taken a back seat for countless years largely owing to its high production LED lighting is rapidly gaining ground in the lighting space in way more recent occasions. With the increasing demand for greener, extra energy effective as nicely as the environmental strain on energy resources in our times is LED the answer to the future of our lighting wants? Exactly where is LED technology headed and does it have the study momentum and industrial backing to take on the light bulb which was perhaps the most life-altering invention of our time?

---

What is the Difference Between Patent and Utility Model?

The invention regular under patent system requires novelty, non-obvious and capable of industrial application. Whereas the invention standard under utility model is lowed to an 'innovative step'. For example an innovation patent can use products or inventions that have already been invented in a new and innovative way to solve a particular challenge.

The following points differentiate in between Patent and Utility Model

Patents

· The invention which has novel, inventive step and industrial application can be protected.

· All new invention or substantial improvement invention can be protected.

· The term of protection is 20 years from the date of filing.

· The expense to obtain and sustain the patent is extremely expensive.

· It requires substantive examination of patent application to validate patentability.

· Longer time [two to five years] is necessary to obtain a patent.

· Patent protection is out there in practically all big countries.

· Patent protection is actively applied.

· Conversion of patent in to utility model is often doable

Utility Model

· The invention which has mainly novelty, but much less or absent in inventive step can be protected.

· All marginal improvement invention can be protected.

· The term of protection is between 7 and 10 years from the date of filing.

· The expense to acquire and sustain it is cheaper.

· It does not demand substantive examination procedure, as it does not demand inventive step.

· To obtain it, requires only less time in the range of 6 months to 1 year.

· Protection is out there only in some countries based on the technologies.

· Protection is less actively used.

· Converting it in to a patent is doable under certain circumstances.

How To Get Trademark, Logo, Brand, Patent Registration In India

India is one of the nations of the world with the amazing business enterprise opportunities. That attracts western countries to visit India with their business enterprise proposals. This makes India with varieties of companies that offer you various form of products and services to international industry. This raises the demand of law firms in India that helps in handling a variety of types of enterprise issues. There are a number of law firms operating via the India offering wide varieties of corporation law services at affordable rates. These law firms in India normally comprises a sizeable team of well qualified and experienced attorneys and lawyers that have awesome experience of handling diverse kinds of business troubles. Law firm like trademarkregistrationindia.com that presents varieties of services like India trademark registration, India Trademark Lawyer, Trademark Brand, Trademark Litigation, Trademark Protection, Trademark Application, Trademark Classification, Patent Registration, India , Firm Registration, Company Registration in India, Brand Registration, Logo Registration in India, Trademark Registration India and lots a lot more.   
Amongst these services is 1 of the famous and favored services that act as effective tool in giving unique identity to the product. Brand name may possibly be in the form of image, symbol or word. It is quite critical for any kind of organization or company houses to get brand registration. Before submitting brand registration form it is particularly important to check that brand name should certainly not be comparable or identical with any other brand name. Following brand name there is one other registration with the patent registration that includes an exclusive proper given to a individual for his or her new and useful invention in the form of item or services. Besides these trademark registration is another services that every single company property is advised to have in order to get legal advantages. Trademark registration is particularly significant to get one of a kind identification in the corporate market in respect of company's product and service of any type. Trademark is any of type may possibly be symbol, image, word, phase or logo. Just about every country has its own guidelines and procedures for trademark registration.

Besides copyright and logo registration is another very well-known and normal term utilised in corporate industry that includes an intellectual property of a individual that protects the original function done by the author that includes literary dramatic or artistic function. Copyright does not defend the ideas, details, technique or program of operation while it protects the way they are expressed. Form four is made use of for requesting copyright registration. Apart from this logo registration is also 1 of the popular terms applied globally. It is also registered as service marks or trade mark.

Secure Your Invention

Filing for a provisional patent is incredibly critical nowadays. It protects inventors from others who would want to steal their rights. By all indicates, if you are preparing to produce a thing which is far distinct from other items, it is highly advised to give some thought to filing a provisional patent to secure your lifetime fortune along the way.

What is provisional patent? According to the United States Patent and Trademark Office (USPTO), provisional patent is a solid way to protect varied creations under limited circumstances given to an inventor and it is deemed permanent if specific methods are taken into consideration inside a specified time.

In an instance, when you try to apply for provisional patent, you need to have to prepare several documents that would prove the uniqueness of your invention you could possibly consult a patent lawyer if it is important. Right after you submit all the requirements to the United States Patent and Trademark Workplace (USPTO), and the office approved your application, you will be given adequate time to procedure and develop your creation under the bulwark of provisional patency laws. Even just before it is getting launched in the public, it is clearly mandated under such laws that nobody has the ideal to copy or dismantle what you function hard for. In brief, with provisional patent, you have the assurance that those who violate your rights as the sole inventor will reap a variety of consequences which incorporate monetary and other charges when they are proven guilty.

Taking into consideration that your time has nearly lapsed, you need to pay a visit to USPTO once more. This time, you will need to file for normal patent application. This will serve as your lifetime protection. Then again, before the office will grant your petition, you have to have to prove that your invention will not cause any harm to the environment as nicely as to the people today around. Alot more so, you also require to prove that your invention is not labeled as "whimsical". In this occasion, you will need to consult a researcher and a lawyer once again to arrange all the required documents to solidify your claim.

Granting the USPTO has approved your application it is assumed that you are entitled to carry out your products in the public and this time around you are already protected under the typical patency laws. With typical patent, you are entitled for a lifetime protection.

On the other, if the office will not approve your application under various circumstances, you can file an appeal to reconsider your case, then again it will take longer time again just before a selection will be created. That is why, before initiating any methods, it is extremely suggested to seek opinions and legal tips to limit the capital, time and effort spent during the entire process.

Should an Inventor Have Their Patent Attorney Sign a Non-Disclosure Agreement?

I've been getting a recurring question lately: "Will you sign this Non Disclosure Agreement before I tell you about the invention I want you to write a patent application for?" In some cases, the question is phrased, "how much do you charge to write an NDA that you will then sign so I can tell you about my invention?" This second question is a doozy presenting all sorts of difficulties. Let me me just kill both concerns here: you probably don't will need your patent attorney to sign an NDA when you are considering hiring him (or her) as your patent attorney.

Let's speak about that second question very first. An attorney owes all sorts of ethical duties to his client. The lawyer would be violating any number of them by writing a non disclosure agreement that he will later sign. As a practical matter, I hate to feel that there might be some lawyers who are in fact charging customers to prepare an NDA just so the client can then ask them some concerns about how to patent their invention. The lawyer owes a duty of loyalty to the client, so writing an agreement that benefits the client, possibly at the lawyer's expense (as the signing party), is in all probability barred by ethical rules - difficult to separate the attorney's from the client's.

Normally, it is advisable that both parties signing an agreement have counsel give them some advice on the agreement. The client is represented by the lawyer who drafted the argument. Does that mean the drafting lawyer should then get his own attorney to advise him no matter whether to sign the agreement that he in fact wrote? The entire circumstance is particularly odd. And finding paid to be put in that scenario is even weirder. And likely unethical. So let's drop that 1.

Onto the initial question: really should a lawyer sign an NDA just before the inventor discloses his idea to him? Possibly not. Attorneys commonly owe a duty of confidentiality, imposed by state law, to their clients. Patent attorneys are also topic to federal rules that require client facts be kept confidential. But then the question arises of whether or not an inventor who is calling to get some fundamental facts about fees and the patent approach is actually a client. This depends on quite a few factors, and it could undoubtedly be argued that the inventor is not but a client, which means the lawyer may possibly not have an obligation to preserve the divulged information confidential. This has all sorts of ramifications on the inventor's capacity to file for patent protection in the US and abroad.

So what is the remedy? How can an inventor get basic assistance without having risking disclosure of his concept? An inventor could try going to one lawyer, have them draft an NDA, and then take that to the patent lawyer to sign before initiating the attorney-client relationship. But this presents troubles of its own, beyond the obvious cost issues. An lawyer have to make confident, ahead of representing a client, that the representation wouldn't cause any conflict of interest with any current or past customers. Producing this determination would be fairly difficult prior to understanding the rough boundaries of what the client demands.

Maybe the inventor could tell the lawyer only honestly standard information about the invention - not sufficient to trigger disclosure, but sufficient that the attorney could get an notion about the invention? Once again, difficult to do. Most attorneys will want to describe the invention to some extent in the engagement letter so that it is clear exactly what the representation will entail. And for patent attorneys who practice in niche fields - opto-electrical sensors, balloon catheter medical devices, etc. - a "fundamental" description probably isn't going to suffice.

I propose that you rely on two points: trust and faith. Most attorneys can be trusted. And most attorneys aren't businesspeople or inventors or seeking to expand their income stream. What I mean by this is that they aren't your competition, they're quite possibly not going to steal your concept and try to market place it themselves. And when I say you ought to rely on faith, I'm guessing that the Patent Workplace would by no means refuse your patent application based on a disclosure to an lawyer, nor would a court invalidate your patent given that you shopped it about to two or three attorneys prior to picking one. Have some faith that the courts would locate there does exist a duty of confidentiality extending to prospective patent clients. I'm going to do some research to see if there is any case law exactly where an inventor was prevented from finding a patent for the reason that he disclosed it to an attorney and then waited too lengthy to file the application. I highly doubt there is any frequently, that sort of disclosure happens when it is produced to a convention audience, or pals and loved ones, not to an lawyer who has a usually recognized duty of confidentiality.

Is There Too Much Information Available for Inventors?

With the government recently launching a new initiative to promote and encourage the innovation industry, a sudden wealth of information and facts and literature has begun to emerge in each physical and virtual form to 'assist' would-be inventors and entrepreneurs. But are all these sources of facts definitely beneficial? For the individual inventor embarking on such a journey, with no prior information of the business, it is hard to know what is accurate and, far more importantly perhaps, which sources can be trusted.

The places of intellectual property and item style and development can be complicated for the most experienced specialists and the lack of 'common knowledge' on such topics makes it tricky for amateurs or beginners to involve and benefit themselves. Consequently, some universities are currently looking to introduce intellectual property units into their courses, such as Small business Studies, to create students' understanding of the processes involved and the close relationship they have with many aspects of the world around us, particularly the company globe. This will in time support the subsequent generation to a lot more comprehensively method intellectual property and product development, with the hope of economical and commercial reward, but what for our existing generation of hopefuls?

The existing readily available literature predominantly takes the form of bookshop 'guidebooks' and Internet articles that all claim to 'explain' intellectual property, item style and their processes, or at least seek to point beginners in the perfect direction. These additional usually than not will comprise '"leading ten's" or "how to's" which although on the surface appear to simplify 'the process', tend to deliver highly little genuine, and regularly conflicting, info.

The most imperative aspect for any inventor is precisely what material can be trusted, as the wrong facts concerning intellectual property could potentially jeopardise a project. The predominant issue, in this regard, is sourcing data from the right geographical constituency in which the very same laws apply. An American article on the procedure of protecting a design, per se, will in no way apply to an English applicant, as the 'design patent' procedure upheld in the USA, and some other countries, is not out there in the UK.

So the vital factor is the source of the information, but possibly for extra causes than merely their country of residence. It is frequently stated that there is no such factor as a selfless act and that at the very least an act is conducted for self-gratification. This theory is frequently true of post writing, particularly within a home business setting, but predominantly for monetary purposes. At the heart of any informative material you will, virtually with out any exception, locate a provider or individual seeking to reap the rewards and rewards from the transfer of their information and specialist wisdom. With informative books the rewards are apparent: the revenue they gain per sale. With web-based material the rewards are seemingly much less apparent and the content is ironically far more useful - as any 'in gratis' info will undoubtedly attract additional readers. As such, this material consequently becomes zero cost advertising and a priceless advertising tool for any organization.

So the question arises: is this web material genuinely useful advice and info, or just a company's egotistical self-promotion? The majority of post based details that appears on the net is purely for the purposes of link developing. Even though the content could possibly be genuine the purpose is not to selflessly aid others but to create material that will help in search engine optimisation and other such on-line advertising approaches. This begs the questions as to the validity of the content material of each and every piece. Even though articles on intellectual property and item development are presumably based on factual data, it is the tone, context and purpose that are quite often questionable.

All written material is manipulative, no matter if intentional or not - some may perhaps call it influential - but either way the finish result is the identical: to make a reader side with the opinion of the author. Taking into account the aforementioned presumption that behind such material is an author employed by a enterprise whose services are directly affiliated with the article's content, then it becomes just about evident that naturally the tone will be persuasive: to make a reader want to use the services offered by their company. This is conducted in much the very same way as copy from a company's web-site would be scripted: to manipulate a reader and, in turn, sell themselves. As a result, such post writing becomes an extension of this and seeks to do nothing far more than sell a product, service or other.

To present a fair case, it is reasonable to assume that this might not always be the case and that some articles may be written independently of a company's advertising strategy. Even so, in these instances it could be asked how unbiased an post can truly be? It is challenging to convey any advice or facts entirely cost-free of any opinion of the author, as each and every specialist is influenced by their own career experiences. An article written by a patent lawyer on the exact same topic as a patent examiner may perhaps differ, due to the nature of their roles and the numerous stand points they may take, as a result.

With these thoughts in mind, it leaves us asking yourself who specifically a new inventor can turn to for unbiased, genuine assistance in moving forward? Government sources might possibly be the answer as they seek to simplify such processes, in order to make innovation accessible by the everyman. In relation to this subject, an institution such as the UK Intellectual Property Workplace would be a relevant department that offers useful information and facts for upcoming entrepreneurs. Then again, even these resources seek to acquire from offering such info, as no intellectual property application comes with no its costs.

It would be complicated to write an write-up such as this with out noting the distinct hint of irony embedded in the content material but the purpose is to provoke thought based on my 'opinion'. Possibly the answer is to trust instinct and intuition but most importantly to check sources and gather information from a range of informants prior to forming an opinion of your own. For the individual inventor, the processes to take a product to marketplace can be challenging adequate with no getting influenced by misleading details along the way. Free of charge suggestions from expert bodies is invaluable but most importantly, with any new project, what is paramount is to remain open-minded all through the innovation procedure.

Patent Costs Timetable for the Independent Inventor - Be Prepared Before You Draft!

As an skilled patent professional and a proud father of nine kids, I like to compare writing a patent to having a baby. Like getting a baby, the patenting method begins with superb difficulties and costs, and, like youngsters, the difficulties and costs enhance more than time. Like youngsters, correct preparation before you start can save a lot of cash and heartache later.

Lots of applicants invest considerable dollars into a patent's application in various countries and later understand that they don't have enough money to prosecute examination and are forced to abandon the applications. The result is loss of all capital investments, and loss of the notion (which has been published and becomes public domain).

In Short: just before you start out writing a patent application: 1) make sure that you are certain what you are patenting and that it is honestly a beneficial thought two) make a thorough patentability search (see our previous blog) three) plan what you are going to do with the thought sell/license/or market place 4) Make a price timeline for Looking/Drafting/Prosecuting/Litigation and five) plan how you are going to get the revenue to cover expenses.

The quantity of time and expense of patenting an notion is variable. It is achievable (and often advantageous) to draw out the patenting procedure. It is also probable (and oftentimes advantageous) to hurry the procedure. Acquiring a patent in a foreign country is normally much significantly more pricey than acquiring a patent in the US. Patenting techniques and foreign filings are complicated troubles which I will not talk about here.

Ahead of you put out a lot of income on patents, program for upcoming expenses and be ready to pay. Request from your lawyer/agent an estimate of expenses prior to you agree to any function. Make sure you know what is and is not covered in the estimate. If there are technical errors or corrections to the drawings, who will pay? Do you have to pay extra for filing the IDS (Data Disclosure Statement)? Herein I present a rough price estimate for acquiring a new patent (in the United States):

1) Make a thorough prior art search. To do a appropriate search you need to have to have a clear notion of your invention. You ought to get started by carrying out a search yourself and if you stay convinced that your thought has value hire a patent agent/lawyer to do a a great deal more thorough search. Beware of cheap, one-shot searches. They are pretty much by no means adequate. (A great deal more detailed on searching and some on-line resources are out there in my previous weblog.)

two) File a US provisional application: minimum cost = $100 USPTO fee. I advocate writing your own description of your invention and giving it to a patent agent to check for enablement. You can file it oneself or have your agent file. By the end of a year the provisional expires and you should file a full application to preserve your rights. Make use of that year. Be sure that properly before the finish of the year you have your invention in a final working form and you have adequate money for the filing the full application.

three) Draft and file a US application. The USPTO filing fee is around $500, you may possibly file oneself, but drafting a patent is a tricky approach and not suggested for the uninitiated. Law firms charge from $5000 to $15,000 to draft a common application. Individual patent agents can be discovered who will frequently do a much better job at a lower price. You can aid your attorney/agent by supplying a clear description of the invention. You can save revenue by supplying your attorney with patent good quality drawings (BLACK and WHITE no color no gray shading) (for a lot more on how to make drawings see How to Make Patent Drawings by David Pressman). There are a number of superb books for the layman on patent drafting e.g. Patent It Your self by David Pressman, and The Patent Writer by Bob DeMatteis et al.

A word for the wise It is tempting to save revenue on patent drafting, but it is not advised. A poorly drafted patent may perhaps be invalid or unenforceable. A clear, concise, nicely written application will save time and money for the duration of examination. Also a properly written application is significantly more most likely to attract investors.

4) Patent examination (prosecution) costs are exceptionally variable and difficult to predict. In the ideal case scenario, after 1-3 years a patent undergoes examination entailing 2 to four workplace actions costing from $2000 to $4000 every for a total of about $10,000 to $20,000. Be aware, if you believe your patent is worthwhile, you have to have to have a lot much more money obtainable, considering sometimes it is vital to apply for an RCE (request for continued examination) a divisional application or an appeal of a selection of the examiner. In such instances the costs could be considerably more.

Immediately after an application is allowed, you need to pay an issuance fee of about $1500 and upkeep fees at three.5, 7.five and 11.five years immediately after grant.

Starting Your Career As An Intellectual Property Lawyer

It is necessary to realize what 'intellectual property law' is in real sense. It is a law that defends the creations of designers, musicians, authors and inventors, hence everything that is the product of human mind.

Usually, an intellectual lawyer is considered as multi-talented expert who specializes in copyright law, trademark law, patent law, and trade secret law. An intellectual property law is responsible for drafting patent applications and other legal documentation. He favors his clients and defends them against infringement. Intellectual property lawyers will need to have technical as effectively as entrepreneurial backgrounds in order to deal with the cases correctly.

1. Earn your 4 years of college or university degree with very good grades and an overall high GPA. During your college or university period, try to develop some expertise such as reading, writing, reasoning, situation solving and analytical skills. These will assist you in your law studies. Your selected courses usually are not necessary for your admission, but your great GPA surely is. Make sure that you preserve a fantastic grades and a high GPA for the duration of your university or college time.

2. The next vital condition to get into a law school is to take and pass the Law School Admission Test (LSAT) with superior score. You can take this test even more than one time, depending on the score you want to obtain in the test. This test is organized by the Law School Administration Council 4 occasions a year. Your GPA and LSAT score are really very important.

three. Prepare all the documents that are necessary to build a strong application file. Typically, an application file consists of school records, LSAT scores, a detailed resume with all added-curricular activities and operate knowledge if any, letter of recommendations and an application form. Lots of schools also need statements of motivation and admission essays. Make certain that you have all these documents in hand prior to the deadlines.

4. Make confident that you send your admission application form to the law school or schools before the deadline. Admission procedure often takes few months to total. You can use this time to get an internship or component-time job in any law firm or any other organizations to gain some perform encounter prior to the law school begins.

five. In your 1st year of law school, you will learn about the basics of federal and state law method. In the second and third year you will get a likelihood to opt for courses that you want to specialize in, to say, intellectual property law.

6. During your law school, try to get an internship in law firm offers with intellectual property cases. This will assist you acquire some encounter about the specialist operating environment. Sustain some superb repute throughout your internship, so that after graduating you may get the full time job here.

7. Earn your JD degree to get yourself eligible to sit in a bar exam. By clearing a bar exam, you will obtain your license to begin practicing law as intellectual property.

The Problem With Patent Due Diligence in Mergers and Acquisitions and How to Fix It

As a company or investment professional involved in mergers and acquisitions ("M & A"), are you conducting patent due diligence according to the standard practices of your M & A attorneys and investment bankers? When patents form a considerable aspect of the value of the transaction, you are quite possibly finding incorrect suggestions about how to conduct due diligence. The due diligence procedure must take into consideration the competitive patent landscape. If competitive patents are not included in your vetting procedure, you may be substantially overvaluing the target organization.

In my various years of intellectual property and patent encounter, I have been involved in a number of M & A transactions exactly where patents formed a significant portion of the underlying value of the deal. As the patent specialist on these transactions, I took direction from very compensated M & A attorneys and investment bankers who had been acknowledged by C-level management to be the "real specialists" since they completed dozens of deals a year. To this finish, we patent specialists were directed to check the following 4 boxes on the patent due diligence checklist:

• Are the patents paid up in the Patent Office?
• Does the seller honestly own the patents?
• Do at least some of the patent claims cover the seller's items?
• Did the seller's patent lawyer make any stupid errors that would make the patents challenging to enforce in court?

When these boxes were marked "complete" on the due diligence checklist, the M & A attorneys and investment bankers had efficiently "CYA'd" the patent issues and were free of charge from liability relating to patents in the transaction.

I have no doubt that I conducted my patent due diligence duties very competently and that I, too, had "CYA'd" myself in these transactions. On the other hand, it is now evident that the patent aspect of M & A due diligence essentially conformed to someone's concept of how not to make stupid errors on a transaction involving patents. In truth, I never felt rather comfortable with the "flyover" really feel of patent due diligence, but I did not have choice rights to contradict the normal operating procedures of the M & A professionals. And, I identified out just how incomplete the normal patent due diligence approach is when I was left to pick up the pieces of a transaction conducted according to common M & A process.

In that transaction, my client, a large manufacturer, sought to expand its non-commodity product offerings by acquiring "CleanCo", a tiny manufacturer of a patented consumer product. My client discovered CleanCo to be a very good target for acquisition due to the fact CleanCo's product met a strong consumer require and, at that time, commanded a premium price in the industry. Due to robust consumer acceptance for its sole item, CleanCo was experiencing tremendous growth in sales and that growth was expected to continue. Having said that, CleanCo owned only a smaller manufacturing plant and it was getting difficulty in meeting the growing wants of the industry. CleanCo's venture capital investors had been also anxious to money out after quite a few years of continued funding of the company's somewhat marginal operations. The marriage of my client and CleanCo thus seemed a beneficial match, and the M & A due diligence process got underway.

Due diligence revealed that CleanCo had few assets: the small manufacturing plant, limited but growing sales and distribution and several patents covering the sole CleanCo product. Notwithstanding these apparently minimal assets, CleanCo's asking price was upwards of $150 million. This cost could only mean 1 thing: CleanCo's value could only be in the potential for sales growth of its patented item. In this scenario, the exclusive nature of the CleanCo product was appropriately understood to be basic to the purchase. That is, if someone could knock-off CleanCo's differentiated item, competition would invariably result and ll bets would then be off for the growth and sales projections that formed the basis of the monetary models driving the acquisition.

Taking my directions from the M & A attorney and investment banker leaders in the transaction, I conducted the patent elements of the due diligence method according to their common procedures. Every little thing checked out. CleanCo owned the patents and had kept the charges paid. CleanCo's patent attorney had carried out a fine job on the patents: the CleanCo product was covered well by the patents and there were no obvious legal errors created in obtaining the patents. So, I gave the transaction the thumbs up from the patent perspective. When everything else looked positive, my client became the proud owner of CleanCo and its product.

Fast forward several months . . . . I began to get frequent calls from many people on my client's promoting team focused on the CleanCo product about competitive merchandise that were being noticed in the field. Given the reality that alot more than $150 million was spent on the CleanCo acquisition, these advertising and marketing specialists not surprisingly believed that the competitive products must be infringing the CleanCo patents. On the other hand, I identified that every of these competitive merchandise was a legitimate design-about of the patented CleanCo product. Considering these knock-offs had been not illegal, my client had no way of finding these competitive merchandise removed from the marketplace using legal action.

As a result of this escalating competition for the CleanCo item, cost erosion began to happen. The economic projections that formed the basis of my client's acquisition of CleanCo began to break down. The CleanCo item still sells strongly, but with this unanticipated competition, my client's expected margins are not getting created and its investment in CleanCo will take considerably more time and pricey promoting to pay off. In brief, to date, the $150 Million acquisition of CleanCo looks to be a bust.

In hindsight, the competition for the CleanCo item could have been anticipated throughout the M & A due diligence approach. As we identified out later, a search of the patent literature would have revealed that numerous other methods existed to address the consumer will need addressed by the CleanCo product. CleanCo's achievement in the marketplace now appears to be due to first mover benefit, as opposed to any actual technological or cost advantage provided by the item.

If I knew then what I know now, I would have counseled strongly against the expectation that the CleanCo item would command a premium price due to market exclusivity. Rather, I would demonstrate to the M & A team that competition in the CleanCo product was attainable and, indeed, extremely most likely as revealed by the myriad of solutions to the similar situation shown in the patent literature. The deal could possibly nonetheless have go by means of, but I believe that the the monetary models driving the acquisition would be extra reality-based. As a result, my client could have formulated a marketing and advertising plan that was grounded in an understanding that competition was not only probable, but also most likely. The advertising program would then have been on the offense, rather than on the defense. And, I know that my client did not anticipate to be on the defense following spending extra than $150 million on the CleanCo acquisition.